Laboratory Operating Cash Flow Per Share from 2010 to 2024

LH Stock  USD 216.57  3.05  1.43%   
Laboratory's Operating Cash Flow Per Share is increasing with slightly volatile movements from year to year. Operating Cash Flow Per Share is estimated to finish at 16.01 this year. Operating Cash Flow Per Share is a measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis. View All Fundamentals
 
Operating Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
15.24339839
Current Value
16.01
Quarterly Volatility
7.11205839
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 1.9 B, as well as many exotic indicators such as Short Term Coverage Ratios of 1.08, Price Earnings Ratio of 49.73 or Price To Sales Ratio of 1.6. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
This module can also supplement Laboratory's financial leverage analysis and stock options assessment as well as various Laboratory Technical models . Check out the analysis of Laboratory Correlation against competitors.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.

Latest Laboratory's Operating Cash Flow Per Share Growth Pattern

Below is the plot of the Operating Cash Flow Per Share of Laboratory over the last few years. It is a measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis. Laboratory's Operating Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Operating Cash Flow Per Share10 Years Trend
Slightly volatile
   Operating Cash Flow Per Share   
       Timeline  

Laboratory Operating Cash Flow Per Share Regression Statistics

Arithmetic Mean13.77
Geometric Mean11.84
Coefficient Of Variation51.65
Mean Deviation5.07
Median12.87
Standard Deviation7.11
Sample Variance50.58
Range30.3539
R-Value0.75
Mean Square Error23.67
R-Squared0.57
Significance0
Slope1.20
Total Sum of Squares708.14

Laboratory Operating Cash Flow Per Share History

2024 16.01
2023 15.24
2022 20.06
2021 32.16
2020 21.95
2019 14.76
2018 12.87

About Laboratory Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Laboratory income statement, its balance sheet, and the statement of cash flows. Laboratory investors use historical funamental indicators, such as Laboratory's Operating Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Laboratory investors may use each financial statement separately, they are all related. The changes in Laboratory's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Laboratory's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Laboratory Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Laboratory. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Operating Cash Flow Per Share 15.24  16.01 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Stock:
Check out the analysis of Laboratory Correlation against competitors.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Dividend Share
2.88
Earnings Share
4.33
Revenue Per Share
139.628
Quarterly Revenue Growth
0.035
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.